AI scribes are being rapidly adopted in US healthcare to alleviate documentation burdens, but their implementation lacks empirical evaluation.
2
Uncorrected inaccuracies in AI-generated notes can compromise patient safety, therapeutic efficacy, and trust in healthcare.
3
AI scribes struggle to capture nuances of human communication, raising concerns about bias and ableism in sensitive clinical contexts.
4
Privacy risks are heightened by cloud-based storage and third-party involvement, with inadequate consent processes for patients.
5
The authors advocate for regulatory approval and standardized performance metrics to ensure the safe and effective use of AI scribes.
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.